Janet E. Robertson

NICE guidance on dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma.

N. Umeweni, J. Adam, Janet Robertson, 2014, The Lancet. Oncology.

NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma.

J. Adam, Janet Robertson, Sally Doss, 2014, The Lancet. Oncology.

Introduction and Methods

C. McConkey, J. Waterhouse, H. R. Matthews, 2002 .

NICE guidance on pembrolizumab for advanced melanoma.

I. Watson, E. J. Adam, E. Donegan, 2016, The Lancet. Oncology.